LZResearcher profile · from public sources
Laurence Zitvogel
Targets
Filled chips are declared by the researcher; the others come from publications (number of works).
Now
Trials, publications and grants since Nov 2024.
Publication
Neoadjuvant botensilimab with or without balstilimab in pMMR and dMMR colon cancer: the phase 2 UNICORN trial.
Nature medicine, Nov 2026
Publication
Safety and efficacy of intratumoural anti-CTLA4 with intravenous anti-PD1.
Nature, Apr 2026
Publication
Circulating Transcriptome Analysis Finds Gene Signatures and Immune Cell Activation and Abundance Predict Response to Immunotherapy in Bladder Cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research, Apr 2026
Publication
Harnessing lipid-driven immunometabolic pathways in omental metastases to enhance immunotherapy in patients with ovarian cancer.
Signal transduction and targeted therapy, Mar 2026
Publication
Neutralization of acyl-CoA-binding protein attenuates glucocorticoid-mediated suppression of cancer immunosurveillance.
Proceedings of the National Academy of Sciences of the United States of America, Mar 2026
Publication
Fecal microbiota transplantation plus immunotherapy in non-small cell lung cancer and melanoma: the phase 2 FMT-LUMINate trial.
Nature medicine, Jan 2026
Publication
Fecal microbiota transplantation plus pembrolizumab and axitinib in metastatic renal cell carcinoma: the randomized phase 2 TACITO trial.
Nature medicine, Jan 2026
Publication
Soluble MAdCAM-1 as a biomarker in metastatic renal cell carcinoma.
Nature medicine, Jan 2026
Publication
Tryptophan metabolite indole-3-acetate: a new culprit in irinotecan-induced gut epithelial injury.
Gut, Dec 2025
Publication
Increased plasma concentrations of acyl-coenzyme A binding protein (ACBP) predict future lung cancer development in smokers at risk of cardiovascular disease.
Molecular cancer, Nov 2025
Preprint
Gut microbiota: a new factor modulating the immunizing potential of viral and cancer vaccines.
Research square, Oct 2025
Publication
Pooled analysis of 3,741 stool metagenomes from 18 cohorts for cross-stage and strain-level reproducible microbial biomarkers of colorectal cancer.
Nature medicine, Jun 2025
Co-authors
Who links you
Enter another researcher's profile link or ID to see who has published with both of you.
You have published with Guido Kroemer directly.
Is this you? Request a correction or removal: support@frontlightresearch.com
Report an error